27-29 April 2027
Congress Center HamburgHamburg, Germany Deborah Hol-SchopPrincipal Scientist Upstream Processes at ByondisSpeaker
Profile
Deborah Hol has obtained her PhD degree from Twente University in The Netherlands were her research focused on growth and cellular metabolism of stem cells in bioreactor systems. She continued her career within Byondis (formerly known as Synthon Biopharmaceuticals) in The Netherlands eleven years ago, where she has, in several roles, been involved in the development and technology transfers of bioreactor processes for antibody production for clinical phase 1 to phase 3 studies towards commercialization.
Agenda Sessions
Accelerating early biologics development through the use of stable non-clonal line pools in manufacturing
, 11:45View Session